Back to today’s briefing

Story perspectives

Gene-Editing Pioneer He Jiankui Eyes Comeback After Prison

1/21/2026

37 6

Summary

Story summary

He Jiankui aims to push forward gene-editing work after serving three years in prison for misleading authorities.
He is pursuing gene therapy for Duchenne muscular dystrophy and exploring germline editing to prevent Alzheimer's.
He claims support from a pharmaceutical company and other funders.
Within China’s biotech landscape, he is vocal about ambitions and viewed as a potential asset.

1 of 1

Story summary

He Jiankui aims to push forward gene-editing work after serving three years in prison for misleading authorities.
He is pursuing gene therapy for Duchenne muscular dystrophy and exploring germline editing to prevent Alzheimer's.
He claims support from a pharmaceutical company and other funders.
Within China’s biotech landscape, he is vocal about ambitions and viewed as a potential asset.